Global Sterile Infusions Compounding Pharmacy Market Growth (Status and Outlook) 2025-2031

February 2025 | 127 pages | ID: GA354C529675EN
LP Information

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Sterile Infusions Compounding Pharmacy Market Size (2020-2031)
  2.1.2 Sterile Infusions Compounding Pharmacy Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Sterile Infusions Compounding Pharmacy by Country/Region (2020, 2024 & 2031)
2.2 Sterile Infusions Compounding Pharmacy Segment by Type
  2.2.1 Anti-infectives
  2.2.2 Blood Factors
  2.2.3 Immunotherapies
  2.2.4 Others
2.3 Sterile Infusions Compounding Pharmacy Market Size by Type
  2.3.1 Sterile Infusions Compounding Pharmacy Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Type (2020-2025)
2.4 Sterile Infusions Compounding Pharmacy Segment by Application
  2.4.1 Consumers Aged 18 and Younger
  2.4.2 Consumers Aged 19 to
  2.4.3 Consumers Aged 45 to
  2.4.4 Consumers Aged 65 and Older
2.5 Sterile Infusions Compounding Pharmacy Market Size by Application
  2.5.1 Sterile Infusions Compounding Pharmacy Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2020-2025)

3 STERILE INFUSIONS COMPOUNDING PHARMACY MARKET SIZE BY PLAYER

3.1 Sterile Infusions Compounding Pharmacy Market Size Market Share by Player
  3.1.1 Global Sterile Infusions Compounding Pharmacy Revenue by Player (2020-2025)
  3.1.2 Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Player (2020-2025)
3.2 Global Sterile Infusions Compounding Pharmacy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 STERILE INFUSIONS COMPOUNDING PHARMACY BY REGION

4.1 Sterile Infusions Compounding Pharmacy Market Size by Region (2020-2025)
4.2 Global Sterile Infusions Compounding Pharmacy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Sterile Infusions Compounding Pharmacy Market Size Growth (2020-2025)
4.4 APAC Sterile Infusions Compounding Pharmacy Market Size Growth (2020-2025)
4.5 Europe Sterile Infusions Compounding Pharmacy Market Size Growth (2020-2025)
4.6 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025)
5.2 Americas Sterile Infusions Compounding Pharmacy Market Size by Type (2020-2025)
5.3 Americas Sterile Infusions Compounding Pharmacy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Sterile Infusions Compounding Pharmacy Market Size by Region (2020-2025)
6.2 APAC Sterile Infusions Compounding Pharmacy Market Size by Type (2020-2025)
6.3 APAC Sterile Infusions Compounding Pharmacy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025)
7.2 Europe Sterile Infusions Compounding Pharmacy Market Size by Type (2020-2025)
7.3 Europe Sterile Infusions Compounding Pharmacy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Sterile Infusions Compounding Pharmacy by Region (2020-2025)
8.2 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Type (2020-2025)
8.3 Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL STERILE INFUSIONS COMPOUNDING PHARMACY MARKET FORECAST

10.1 Global Sterile Infusions Compounding Pharmacy Forecast by Region (2026-2031)
  10.1.1 Global Sterile Infusions Compounding Pharmacy Forecast by Region (2026-2031)
  10.1.2 Americas Sterile Infusions Compounding Pharmacy Forecast
  10.1.3 APAC Sterile Infusions Compounding Pharmacy Forecast
  10.1.4 Europe Sterile Infusions Compounding Pharmacy Forecast
  10.1.5 Middle East & Africa Sterile Infusions Compounding Pharmacy Forecast
10.2 Americas Sterile Infusions Compounding Pharmacy Forecast by Country (2026-2031)
  10.2.1 United States Market Sterile Infusions Compounding Pharmacy Forecast
  10.2.2 Canada Market Sterile Infusions Compounding Pharmacy Forecast
  10.2.3 Mexico Market Sterile Infusions Compounding Pharmacy Forecast
  10.2.4 Brazil Market Sterile Infusions Compounding Pharmacy Forecast
10.3 APAC Sterile Infusions Compounding Pharmacy Forecast by Region (2026-2031)
  10.3.1 China Sterile Infusions Compounding Pharmacy Market Forecast
  10.3.2 Japan Market Sterile Infusions Compounding Pharmacy Forecast
  10.3.3 Korea Market Sterile Infusions Compounding Pharmacy Forecast
  10.3.4 Southeast Asia Market Sterile Infusions Compounding Pharmacy Forecast
  10.3.5 India Market Sterile Infusions Compounding Pharmacy Forecast
  10.3.6 Australia Market Sterile Infusions Compounding Pharmacy Forecast
10.4 Europe Sterile Infusions Compounding Pharmacy Forecast by Country (2026-2031)
  10.4.1 Germany Market Sterile Infusions Compounding Pharmacy Forecast
  10.4.2 France Market Sterile Infusions Compounding Pharmacy Forecast
  10.4.3 UK Market Sterile Infusions Compounding Pharmacy Forecast
  10.4.4 Italy Market Sterile Infusions Compounding Pharmacy Forecast
  10.4.5 Russia Market Sterile Infusions Compounding Pharmacy Forecast
10.5 Middle East & Africa Sterile Infusions Compounding Pharmacy Forecast by Region (2026-2031)
  10.5.1 Egypt Market Sterile Infusions Compounding Pharmacy Forecast
  10.5.2 South Africa Market Sterile Infusions Compounding Pharmacy Forecast
  10.5.3 Israel Market Sterile Infusions Compounding Pharmacy Forecast
  10.5.4 Turkey Market Sterile Infusions Compounding Pharmacy Forecast
10.6 Global Sterile Infusions Compounding Pharmacy Forecast by Type (2026-2031)
10.7 Global Sterile Infusions Compounding Pharmacy Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Sterile Infusions Compounding Pharmacy Forecast

11 KEY PLAYERS ANALYSIS

11.1 Baxter
  11.1.1 Baxter Company Information
  11.1.2 Baxter Sterile Infusions Compounding Pharmacy Product Offered
  11.1.3 Baxter Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Baxter Main Business Overview
  11.1.5 Baxter Latest Developments
11.2 B. Braun
  11.2.1 B. Braun Company Information
  11.2.2 B. Braun Sterile Infusions Compounding Pharmacy Product Offered
  11.2.3 B. Braun Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 B. Braun Main Business Overview
  11.2.5 B. Braun Latest Developments
11.3 Fresenius Kabi
  11.3.1 Fresenius Kabi Company Information
  11.3.2 Fresenius Kabi Sterile Infusions Compounding Pharmacy Product Offered
  11.3.3 Fresenius Kabi Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Fresenius Kabi Main Business Overview
  11.3.5 Fresenius Kabi Latest Developments
11.4 Kelun Pharma
  11.4.1 Kelun Pharma Company Information
  11.4.2 Kelun Pharma Sterile Infusions Compounding Pharmacy Product Offered
  11.4.3 Kelun Pharma Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Kelun Pharma Main Business Overview
  11.4.5 Kelun Pharma Latest Developments
11.5 Otsuka Pharmaceutical
  11.5.1 Otsuka Pharmaceutical Company Information
  11.5.2 Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
  11.5.3 Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Otsuka Pharmaceutical Main Business Overview
  11.5.5 Otsuka Pharmaceutical Latest Developments
11.6 JW Pharmaceutical
  11.6.1 JW Pharmaceutical Company Information
  11.6.2 JW Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
  11.6.3 JW Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 JW Pharmaceutical Main Business Overview
  11.6.5 JW Pharmaceutical Latest Developments
11.7 Pfizer
  11.7.1 Pfizer Company Information
  11.7.2 Pfizer Sterile Infusions Compounding Pharmacy Product Offered
  11.7.3 Pfizer Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Pfizer Main Business Overview
  11.7.5 Pfizer Latest Developments
11.8 Teva Pharmaceutical
  11.8.1 Teva Pharmaceutical Company Information
  11.8.2 Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
  11.8.3 Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Teva Pharmaceutical Main Business Overview
  11.8.5 Teva Pharmaceutical Latest Developments
11.9 Haisco Pharmaceutical Group
  11.9.1 Haisco Pharmaceutical Group Company Information
  11.9.2 Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Product Offered
  11.9.3 Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Haisco Pharmaceutical Group Main Business Overview
  11.9.5 Haisco Pharmaceutical Group Latest Developments
11.10 King York
  11.10.1 King York Company Information
  11.10.2 King York Sterile Infusions Compounding Pharmacy Product Offered
  11.10.3 King York Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 King York Main Business Overview
  11.10.5 King York Latest Developments
11.11 Cisen
  11.11.1 Cisen Company Information
  11.11.2 Cisen Sterile Infusions Compounding Pharmacy Product Offered
  11.11.3 Cisen Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Cisen Main Business Overview
  11.11.5 Cisen Latest Developments
11.12 Lummy
  11.12.1 Lummy Company Information
  11.12.2 Lummy Sterile Infusions Compounding Pharmacy Product Offered
  11.12.3 Lummy Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Lummy Main Business Overview
  11.12.5 Lummy Latest Developments
11.13 Grand Life Sciences
  11.13.1 Grand Life Sciences Company Information
  11.13.2 Grand Life Sciences Sterile Infusions Compounding Pharmacy Product Offered
  11.13.3 Grand Life Sciences Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Grand Life Sciences Main Business Overview
  11.13.5 Grand Life Sciences Latest Developments
11.14 Medisan
  11.14.1 Medisan Company Information
  11.14.2 Medisan Sterile Infusions Compounding Pharmacy Product Offered
  11.14.3 Medisan Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Medisan Main Business Overview
  11.14.5 Medisan Latest Developments
11.15 BBCA Pharmaceutical
  11.15.1 BBCA Pharmaceutical Company Information
  11.15.2 BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
  11.15.3 BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 BBCA Pharmaceutical Main Business Overview
  11.15.5 BBCA Pharmaceutical Latest Developments
11.16 Biokin Pharmaceutical
  11.16.1 Biokin Pharmaceutical Company Information
  11.16.2 Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
  11.16.3 Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Biokin Pharmaceutical Main Business Overview
  11.16.5 Biokin Pharmaceutical Latest Developments
11.17 Xi'an Libang Pharmaceutical
  11.17.1 Xi'an Libang Pharmaceutical Company Information
  11.17.2 Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
  11.17.3 Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 Xi'an Libang Pharmaceutical Main Business Overview
  11.17.5 Xi'an Libang Pharmaceutical Latest Developments
11.18 Lionco Pharmaceutical
  11.18.1 Lionco Pharmaceutical Company Information
  11.18.2 Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
  11.18.3 Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 Lionco Pharmaceutical Main Business Overview
  11.18.5 Lionco Pharmaceutical Latest Developments
11.19 China Meheco Kangli
  11.19.1 China Meheco Kangli Company Information
  11.19.2 China Meheco Kangli Sterile Infusions Compounding Pharmacy Product Offered
  11.19.3 China Meheco Kangli Sterile Infusions Compounding Pharmacy Revenue, Gross Margin and Market Share (2020-2025)
  11.19.4 China Meheco Kangli Main Business Overview
  11.19.5 China Meheco Kangli Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Sterile Infusions Compounding Pharmacy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Sterile Infusions Compounding Pharmacy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Anti-infectives
Table 4. Major Players of BloodFactors
Table 5. Major Players of Immunotherapies
Table 6. Major Players of Others
Table 7. Sterile Infusions Compounding Pharmacy Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Sterile Infusions Compounding Pharmacy Market Size byType (2020-2025) & ($ millions)
Table 9. Global Sterile Infusions Compounding Pharmacy Market Size Market Share byType (2020-2025)
Table 10. Sterile Infusions Compounding Pharmacy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Sterile Infusions Compounding Pharmacy Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2020-2025)
Table 13. Global Sterile Infusions Compounding Pharmacy Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Player (2020-2025)
Table 15. Sterile Infusions Compounding Pharmacy Key Players Head office and Products Offered
Table 16. Sterile Infusions Compounding Pharmacy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Sterile Infusions Compounding Pharmacy Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Region (2020-2025)
Table 21. Global Sterile Infusions Compounding Pharmacy Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Sterile Infusions Compounding Pharmacy Market Size Market Share by Country (2020-2025)
Table 25. Americas Sterile Infusions Compounding Pharmacy Market Size byType (2020-2025) & ($ millions)
Table 26. Americas Sterile Infusions Compounding Pharmacy Market Size Market Share byType (2020-2025)
Table 27. Americas Sterile Infusions Compounding Pharmacy Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2020-2025)
Table 29. APAC Sterile Infusions Compounding Pharmacy Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Sterile Infusions Compounding Pharmacy Market Size Market Share by Region (2020-2025)
Table 31. APAC Sterile Infusions Compounding Pharmacy Market Size byType (2020-2025) & ($ millions)
Table 32. APAC Sterile Infusions Compounding Pharmacy Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Sterile Infusions Compounding Pharmacy Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Sterile Infusions Compounding Pharmacy Market Size Market Share by Country (2020-2025)
Table 35. Europe Sterile Infusions Compounding Pharmacy Market Size byType (2020-2025) & ($ millions)
Table 36. Europe Sterile Infusions Compounding Pharmacy Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size byType (2020-2025) & ($ millions)
Table 39. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Sterile Infusions Compounding Pharmacy
Table 41. Key Market Challenges & Risks of Sterile Infusions Compounding Pharmacy
Table 42. Key IndustryTrends of Sterile Infusions Compounding Pharmacy
Table 43. Global Sterile Infusions Compounding Pharmacy Market SizeForecast by Region (2026-2031) & ($ millions)
Table 44. Global Sterile Infusions Compounding Pharmacy Market Size Market ShareForecast by Region (2026-2031)
Table 45. Global Sterile Infusions Compounding Pharmacy Market SizeForecast byType (2026-2031) & ($ millions)
Table 46. Global Sterile Infusions Compounding Pharmacy Market SizeForecast by Application (2026-2031) & ($ millions)
Table 47. Baxter Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 48. Baxter Sterile Infusions Compounding Pharmacy Product Offered
Table 49. Baxter Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Baxter Main Business
Table 51. Baxter Latest Developments
Table 52. B. Braun Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 53. B. Braun Sterile Infusions Compounding Pharmacy Product Offered
Table 54. B. Braun Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. B. Braun Main Business
Table 56. B. Braun Latest Developments
Table 57.Fresenius Kabi Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 58.Fresenius Kabi Sterile Infusions Compounding Pharmacy Product Offered
Table 59.Fresenius Kabi Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60.Fresenius Kabi Main Business
Table 61.Fresenius Kabi Latest Developments
Table 62. Kelun Pharma Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 63. Kelun Pharma Sterile Infusions Compounding Pharmacy Product Offered
Table 64. Kelun Pharma Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Kelun Pharma Main Business
Table 66. Kelun Pharma Latest Developments
Table 67. Otsuka Pharmaceutical Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 68. Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
Table 69. Otsuka Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Otsuka Pharmaceutical Main Business
Table 71. Otsuka Pharmaceutical Latest Developments
Table 72. JW Pharmaceutical Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 73. JW Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
Table 74. JW Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. JW Pharmaceutical Main Business
Table 76. JW Pharmaceutical Latest Developments
Table 77. Pfizer Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 78. Pfizer Sterile Infusions Compounding Pharmacy Product Offered
Table 79. Pfizer Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82.Teva Pharmaceutical Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 83.Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
Table 84.Teva Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85.Teva Pharmaceutical Main Business
Table 86.Teva Pharmaceutical Latest Developments
Table 87. Haisco Pharmaceutical Group Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 88. Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Product Offered
Table 89. Haisco Pharmaceutical Group Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Haisco Pharmaceutical Group Main Business
Table 91. Haisco Pharmaceutical Group Latest Developments
Table 92. King York Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 93. King York Sterile Infusions Compounding Pharmacy Product Offered
Table 94. King York Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. King York Main Business
Table 96. King York Latest Developments
Table 97. Cisen Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 98. Cisen Sterile Infusions Compounding Pharmacy Product Offered
Table 99. Cisen Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 100. Cisen Main Business
Table 101. Cisen Latest Developments
Table 102. Lummy Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 103. Lummy Sterile Infusions Compounding Pharmacy Product Offered
Table 104. Lummy Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 105. Lummy Main Business
Table 106. Lummy Latest Developments
Table 107. Grand Life Sciences Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 108. Grand Life Sciences Sterile Infusions Compounding Pharmacy Product Offered
Table 109. Grand Life Sciences Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 110. Grand Life Sciences Main Business
Table 111. Grand Life Sciences Latest Developments
Table 112. Medisan Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 113. Medisan Sterile Infusions Compounding Pharmacy Product Offered
Table 114. Medisan Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 115. Medisan Main Business
Table 116. Medisan Latest Developments
Table 117. BBCA Pharmaceutical Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 118. BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
Table 119. BBCA Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 120. BBCA Pharmaceutical Main Business
Table 121. BBCA Pharmaceutical Latest Developments
Table 122. Biokin Pharmaceutical Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 123. Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
Table 124. Biokin Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 125. Biokin Pharmaceutical Main Business
Table 126. Biokin Pharmaceutical Latest Developments
Table 127. Xi'an Libang Pharmaceutical Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 128. Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
Table 129. Xi'an Libang Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 130. Xi'an Libang Pharmaceutical Main Business
Table 131. Xi'an Libang Pharmaceutical Latest Developments
Table 132. Lionco Pharmaceutical Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 133. Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Product Offered
Table 134. Lionco Pharmaceutical Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 135. Lionco Pharmaceutical Main Business
Table 136. Lionco Pharmaceutical Latest Developments
Table 137. China Meheco Kangli Details, CompanyType, Sterile Infusions Compounding Pharmacy Area Served and Its Competitors
Table 138. China Meheco Kangli Sterile Infusions Compounding Pharmacy Product Offered
Table 139. China Meheco Kangli Sterile Infusions Compounding Pharmacy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 140. China Meheco Kangli Main Business
Table 141. China Meheco Kangli Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Sterile Infusions Compounding Pharmacy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sterile Infusions Compounding Pharmacy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Sterile Infusions Compounding Pharmacy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Sterile Infusions Compounding Pharmacy Sales Market Share by Country/Region (2024)
Figure 8. Sterile Infusions Compounding Pharmacy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Sterile Infusions Compounding Pharmacy Market Size Market Share byType in 2024
Figure 10. Sterile Infusions Compounding Pharmacy in Consumers Aged 18 and Younger
Figure 11. Global Sterile Infusions Compounding Pharmacy Market: Consumers Aged 18 and Younger (2020-2025) & ($ millions)
Figure 12. Sterile Infusions Compounding Pharmacy in Consumers Aged 19 to 44
Figure 13. Global Sterile Infusions Compounding Pharmacy Market: Consumers Aged 19 to 44 (2020-2025) & ($ millions)
Figure 14. Sterile Infusions Compounding Pharmacy in Consumers Aged 45 to 64
Figure 15. Global Sterile Infusions Compounding Pharmacy Market: Consumers Aged 45 to 64 (2020-2025) & ($ millions)
Figure 16. Sterile Infusions Compounding Pharmacy in Consumers Aged 65 and Older
Figure 17. Global Sterile Infusions Compounding Pharmacy Market: Consumers Aged 65 and Older (2020-2025) & ($ millions)
Figure 18. Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Application in 2024
Figure 19. Global Sterile Infusions Compounding Pharmacy Revenue Market Share by Player in 2024
Figure 20. Global Sterile Infusions Compounding Pharmacy Market Size Market Share by Region (2020-2025)
Figure 21. Americas Sterile Infusions Compounding Pharmacy Market Size 2020-2025 ($ millions)
Figure 22. APAC Sterile Infusions Compounding Pharmacy Market Size 2020-2025 ($ millions)
Figure 23. Europe Sterile Infusions Compounding Pharmacy Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size 2020-2025 ($ millions)
Figure 25. Americas Sterile Infusions Compounding Pharmacy Value Market Share by Country in 2024
Figure 26. United States Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Sterile Infusions Compounding Pharmacy Market Size Market Share by Region in 2024
Figure 31. APAC Sterile Infusions Compounding Pharmacy Market Size Market Share byType (2020-2025)
Figure 32. APAC Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2020-2025)
Figure 33. China Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 37. India Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Sterile Infusions Compounding Pharmacy Market Size Market Share by Country in 2024
Figure 40. Europe Sterile Infusions Compounding Pharmacy Market Size Market Share byType (2020-2025)
Figure 41. Europe Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2020-2025)
Figure 42. Germany Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 43.France Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Market Share byType (2020-2025)
Figure 49. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 53.Turkey Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Sterile Infusions Compounding Pharmacy Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 56. APAC Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 57. Europe Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 59. United States Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 60. Canada Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 61. Mexico Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 62. Brazil Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 63. China Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 64. Japan Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 65. Korea Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 67. India Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 68. Australia Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 69. Germany Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 70.France Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 71. UK Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 72. Italy Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 73. Russia Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 74. Egypt Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 75. South Africa Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 76. Israel Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 77.Turkey Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)
Figure 78. Global Sterile Infusions Compounding Pharmacy Market Size Market ShareForecast byType (2026-2031)
Figure 79. Global Sterile Infusions Compounding Pharmacy Market Size Market ShareForecast by Application (2026-2031)
Figure 80. GCC Countries Sterile Infusions Compounding Pharmacy Market Size 2026-2031 ($ millions)